The RACE for Children Act: Early Global Impact and Ensuring Success with Pediatric Champions, Upcoming Webinar Hosted by Xtalks
The RACE for Children Act: Early Global Impact and Ensuring Success with Pediatric Champions, Upcoming Webinar Hosted by Xtalks
In this free webinar, the featured speakers will discuss the impact of the RACE for Children Act since it went into effect, from a regulatory, health care professional and industry point of view, both in the USA and globally. They will talk about what a pediatric champion is and why they are needed, and a parent and child's experience of a molecularly targeted therapy.
PR Newswire
TORONTO, Nov. 30, 2020
TORONTO, Nov. 30, 2020 /PRNewswire-PRWeb/ -- After three years of hard work by multiple diverse stakeholders, and with much anticipation, the RACE for Children Act became effective August 18th, 2020. This landmark legislation aims to dramatically shift the global landscape of clinical research in pediatric oncology and intends to bring new molecularly targeted cancer therapeutics to children, who have not been as greatly impacted by precision medicine over the past few decades compared to adults.
Whether the RACE for Children Act leads to the development of more drugs for children with cancer in the USA, and globally, remains to be seen. What can we learn about the global impact of the RACE for Children Act in the first few months since its implementation? What is needed to ensure its ongoing success?
Regulators, researchers, industry and patient advocates have come together to focus on not only curing childhood cancer but reducing long term side effects. Please join us in hearing from them in this webinar on what the early global impact of the RACE for Children Act looks like, and what is needed to ensure its success, including the critical function of pediatric champions.
Join Dr. Gregory Reaman, Associate Director for Pediatric Oncology, Oncology Center of Excellence, Center for Drug Evaluation and Research, US Food and Drug Administration; Prof. Gilles Vassal, Head of Pediatric Research Program, Gustave Roussy/Université Paris-Saclay and President ITCC, Chair of ACCELERATE; Dr. Anjali Sharma, Pediatric Oncology Development Lead and Early Oncology Development Lead, Amgen; and Dr. Beth Anne Baber, Founder & President, TigoHealth, in a live webinar on Thursday, December 17, 2020 at 10am EST (3pm GMT/UK).
For more information, or to register for this event, visit The RACE for Children Act: Early Global Impact and Ensuring Success with Pediatric Champions.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Ayesha Rashid, Xtalks, +1 (416) 977-6555 x 272, arashid@xtalks.com
SOURCE Xtalks
